Hyperuricaemia with deposition: Latest evidence and therapeutic approach

26Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This article reviews recent evidence on urate deposition and the opportunity for a therapeutic approach. We reviewed Pubmed 2013-2015 literature using the search terms ‘deposition' with ‘hyperuricaemia', ‘gout', ‘ultrasonography', ‘DECT' (dual-energy computed tomography), ‘radiography', ‘CT'(computed tomography), ‘MRI' (magnetic resonance imaging), or ‘cardiovascular', in addition to a digital bibliographic library compiled by the authors with 2072 papers on hyperuricaemia and gout. Relevant papers on the topic were selected. Recent evidence, mostly based on imaging studies, showed a continuum from hyperuricaemia to deposition and clinical manifestations. Chronic inflammation and structural damage may be present even in asymptomatic patients with crystal-proved deposition. The impact of early intervention in patients with asymptomatic deposition either on vascular outcomes or further structural joint damage has not been demonstrated yet. In conclusion, a worldwide definition of gout is still lacking, stages from hyperuricaemia to clinical gout not being definitively defined. Although there is increasing interest on the impact of early deposits on joint damage and cardiovascular outcomes, robust evidence is still lacking to fully support interventions. © 2015, SAGE Publications. All rights reserved.

Cite

CITATION STYLE

APA

Perez-Ruiz, F., Marimon, E., & Chinchilla, S. P. (2015). Hyperuricaemia with deposition: Latest evidence and therapeutic approach. Therapeutic Advances in Musculoskeletal Disease. https://doi.org/10.1177/1759720X15599734

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free